References: (1) Goldstein AL, Hannappel E, Sosne G, Kleinman HK
Providers increasingly encounter patients Read More Protecting Muscle While Treating Obesity: New Protein Targets for Older Adults on GLP-1s Jun 16, 2026 Articles, Diet and Nutrition, Exercise, Geriatric Medicine, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Obesity, Obesity 1,660 views The rise of highly effective GLP-1 receptor agonists and dual incretin therapies has transformed obesity treatment
However, additional research is necessary to ensure these findings are reproducible, and the durability of fasting-induced weight loss without ongoing therapeutic support remains uncertain
Testosterone replacement addresses the hormonal component of libido
Strong clinical trial results, widespread physician adoption, and high patient preference for oral administration enhance its market leadership
PepsiCo unveiled a gut-health-friendly soda last year with the launch of Pepsi Prebiotic Cola, which contains 3 grams of prebiotic fiber